Category: Biotechnology
Biotechnology market research reports by DelveInsight
-
Anti GM-CSF Antibody - Pipeline Insight, 2024
Anti GM-CSF Antibody - Pipeline Insight, 2024 “Anti GM-CSF Antibody - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti GM-CSF Antibody development. The report provides detailed cove ... Read More
-
Anti-Mucin 1 (MUC1) Antibody - Pipeline Insight, 2024
Anti-Mucin 1 (MUC1) Antibody - Pipeline Insight, 2024 “Anti-Mucin 1 (MUC1) Antibody - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-Mucin 1 (MUC1) Antibody development. The repor ... Read More
-
Anti-CD19 Antibody - Pipeline Insight, 2024
Anti-CD19 Antibody - Pipeline Insight, 2024 “Anti-CD19 Antibody - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD19 Antibody development. The report provides detailed coverage o ... Read More
-
Anti-CD274 (PD-L1) Antibody - Pipeline Insight, 2024
Anti-CD274 (PD-L1) Antibody - Pipeline Insight, 2024 “Anti-CD274 (PD-L1) Antibody - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD274 (PD-L1) Antibody development. The report p ... Read More
-
Anti-CD52 Antibody - Pipeline Insight, 2024
Anti-CD52 Antibody - Pipeline Insight, 2024 “Anti-CD52 Antibody - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD52 Antibody development. The report provides detailed coverage o ... Read More
-
CAR T-Cell Therapy for Acute Lymphoblastic Leukemia - Pipeline Insight, 2024
CAR T-Cell Therapy for Acute Lymphoblastic Leukemia - Pipeline Insight, 2024 DelveInsight’s, “CAR T-Cell Therapy for Acute Lymphoblastic Leukemia - Pipeline Insight, 2024,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in CAR T-Cell Therapy for Acute Lymphoblastic L ... Read More
-
Allogenic iNKT Cell Therapy - Pipeline Insight, 2024
Allogenic iNKT Cell Therapy - Pipeline Insight, 2024 Allogenic iNKT Cell Therapy Overview ""Allogenic iNKT Cell Therapy Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Allogenic iNKT Cell Therapy ... Read More
-
Gonadotropin-Releasing Hormone (GnRH) Receptor (LHRH Receptor) Antagonist - Pipeline Insight, 2024
Gonadotropin-Releasing Hormone (GnRH) Receptor (LHRH Receptor) Antagonist - Pipeline Insight, 2024 “Gonadotropin-Releasing Hormone (GnRH) Receptor (LHRH Receptor) Antagonist - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutic ... Read More
-
GPCR-Targeting Therapies - Pipeline Insight, 2024
GPCR-Targeting Therapies - Pipeline Insight, 2024 GPCR-Targeting Therapies Overview ""GPCR-Targeting Therapies Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the GPCR-Targeting Therapies market. A de ... Read More
-
CAR T-Cell Therapy for Non-Hodgkin’s lymphoma– - Pipeline Insight, 2024
CAR T-Cell Therapy for Non-Hodgkin’s lymphoma– - Pipeline Insight, 2024 DelveInsight’s, “CAR T-Cell Therapy for Non-Hodgkin’s Lymphoma - Pipeline Insight, 2024,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in CAR T-Cell Therapy for Non-Hodgkin’s Lymphoma pipeline ... Read More
-
Anti-CD3 Antibody - Pipeline Insight, 2024
Anti-CD3 Antibody - Pipeline Insight, 2024 “Anti-CD3 Antibody - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD3 Antibody development. The report provides detailed coverage of t ... Read More
-
Anti-CD33 Antibody - Pipeline Insight, 2024
Anti-CD33 Antibody - Pipeline Insight, 2024 “Anti-CD33 Antibody - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD33 Antibody development. The report provides detailed coverage o ... Read More
-
Anti-CD28 Antibody - Pipeline Insight, 2024
Anti-CD28 Antibody - Pipeline Insight, 2024 “Anti-CD28 Antibody - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD28 Antibody development. The report provides detailed coverage o ... Read More
-
GNE Myopathy - Pipeline Insight, 2024
GNE Myopathy - Pipeline Insight, 2024 GNE Myopathy Overview ""GNE Myopathy Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the GNE Myopathy market. A detailed picture of the GNE Myopathy pipeline land ... Read More
-
Angiotensin Converting Enzyme (ACE) Inhibitor - Pipeline Insight, 2024
Angiotensin Converting Enzyme (ACE) Inhibitor - Pipeline Insight, 2024 “Angiotensin Converting Enzyme (ACE) Inhibitor - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Angiotensin Conve ... Read More
-
Apoptosis Inhibitor - Pipeline Insight, 2024
Apoptosis Inhibitor - Pipeline Insight, 2024 “Apoptosis Inhibitor - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Apoptosis Inhibitor development. The report provides detailed coverag ... Read More
-
Gene therapy in Rare Diseases - Pipeline Insight, 2024
Gene therapy in Rare Diseases - Pipeline Insight, 2024 Gene therapy in Rare Diseases Overview ""Gene therapy in Rare Diseases Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Gene therapy in Rare D ... Read More
-
Gene Therapy For Ocular Rare Disease - Pipeline Insight, 2024
Gene Therapy For Ocular Rare Disease - Pipeline Insight, 2024 Gene Therapy For Ocular Rare Disease Overview ""Gene Therapy For Ocular Rare Disease Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the G ... Read More
-
CAR T-Cell Therapy for Acute Lymphoblastic Leukemia (ALL) - Market Insight, Epidemiology And Market Forecast - 2032
CAR T-Cell Therapy for Acute Lymphoblastic Leukemia (ALL) - Market Insight, Epidemiology And Market Forecast - 2032 Key Highlights Urinary tract infections (UTIs) are amongst the most frequent bacterial infections. They can manifest clinically in various ways, from relatively benign, uncomplicated i ... Read More
-
Molecular Spectroscopy - Global Market Insights, Competitive Landscape, and Market Forecast - 2028
Molecular Spectroscopy - Global Market Insights, Competitive Landscape, and Market Forecast - 2028 Molecular Spectroscopy Market By Type (Mass Spectroscopy, Infrared Spectroscopy, UV-Visible Spectroscopy, NMR Spectroscopy, Raman Spectroscopy, And Others), Application (Pharmaceutical Industries, Food ... Read More
-
Biochips - Global Market Insights, Competitive Landscape, and Market Forecast - 2028
Biochips - Global Market Insights, Competitive Landscape, and Market Forecast - 2028 Biochips Market By Type (DNA Chips, Protein Chips, Lab-On-Chips, And Others), Application (Genomics And Proteomics, Drug Discovery, Diagnostics, IVD & POC, Gene Expression, And Others), End-User (Hospitals And Diagn ... Read More
-
CAR T-Cell Therapy for Non-Hodgkin's lymphoma (NHL) - Market Insight, Epidemiology And Market Forecast - 2032
CAR T-Cell Therapy for Non-Hodgkin's lymphoma (NHL) - Market Insight, Epidemiology And Market Forecast - 2032 Key Highlights In 2023, the market size of epidermolysis bullosa was highest in the US among the 7MM, accounting for approximately USD 1,300 million, which is further expected to increase by ... Read More
-
Gene Therapy in Ophthalmology- Market Insights, Epidemiology, and Market Forecast-2034
Gene Therapy in Ophthalmology- Market Insights, Epidemiology, and Market Forecast-2034 Key Highlights Currently, there is only one approved gene therapy in ophthalmology, that is LUXTURNA, which was approved by the US FDA in December 2017, and by the EU in November 2018. In 2020, the market size of ... Read More
-
Nanomedicine - Market Insights, Competitive Landscape, and Market Forecast - 2028
Nanomedicine - Market Insights, Competitive Landscape, and Market Forecast - 2028 Nanomedicine Market By Molecule Type (Nanoparticle, Nanoshells, Nanotubes, And Nanodevices), Applications (Drug Delivery, Implants, Diagnostic Imaging, Biomaterials, And Others), Indication (Cardiovascular, Oncology, N ... Read More
-
Biopharmaceuticals - Market Insights, Competitive Landscape, and Market Forecast - 2028
Biopharmaceuticals - Market Insights, Competitive Landscape, and Market Forecast - 2028 Biopharmaceuticals Market By Product Type (Monoclonal Antibodies, Recombinant Growth Factors, Purified Protein, Recombinant Protein, Recombinant Hormones, Synthetic Immunomodulators, And Others), Application (Onc ... Read More
Research Assistance
